Director KOL Engagement Epilepsy Launch - Xenon Pharma

Xenon Pharmaceuticals Inc.

United States

Remote

USD 180,000 - 250,000

Full time

44 hours ago
Be an early applicant

Get a reply from this employer

Your resume and cover letter, tailored to exactly what they’re hiring for.

Get past ATS filters

Benefits offered by this job

Tuition assistance
Stock options

Job summary

Xenon Pharmaceuticals Inc. is seeking a Director, Strategic Engagements, Northeast, to join our Commercial team.

This role supports Azetukalner engagement activities and regional market development planning for our epilepsy launch. The ideal candidate has 10+ years in epilepsy marketing or related roles, excels at KOL engagement, stakeholder mapping, and cross-functional leadership, and can manage 50–75% travel while working remotely from the Northeast region.

Qualifications

  • Demonstrated ability to engage KOLs and influential HCPs
  • Strong cross-functional collaboration across Commercial, Medical Affairs, Market Access
  • Experience in epilepsy or CNS therapeutic areas advantageous

Responsibilities

  • Identify, cultivate, and maintain relationships with national and regional epilepsy KOLs and advisors.
  • Own KOL influence mapping, stakeholder profiling, engagement strategies, and communications plans.
  • Monitor stakeholder insights and treatment trends to inform commercial strategy and launch readiness.
  • Serve as strategic advisor to Commercial leadership with market intelligence and recommendations.
  • Lead cross-functional coordination to align customer engagement strategies and execution.
  • Travel 50-75%; lead engagements at national/regional congresses and events.

Skills

KOL engagement
Cross-functional collaboration
Strategic leadership
Epilepsy marketing

Education

BA/BS degree
MBA/PhD preferred

Job description

Director KOL Engagement Epilepsy Launch - Xenon Pharma - Remote

This is a senior-level commercial strategy role at a late-stage biotech company on the cusp of a major product launch. Xenon's azetukalner NDA submission in 2026 makes this a rare opportunity to join a launch team at a critical inflection point - a career-defining moment in pharma.

  • High visibility: The role interfaces directly with senior leadership and national KOLs, offering significant exposure to executive decision-making and commercial strategy.
  • Transferable skills: KOL engagement, stakeholder mapping, cross-functional matrix leadership, and launch readiness are among the most sought-after skills in biopharma commercial roles.
  • Epilepsy specialization: Deep expertise in a niche CNS therapeutic area commands a premium in the job market, particularly as more companies develop novel ASMs.
  • Launch experience: Being part of a first-ever commercial launch for a novel mechanism (Kv7 modulator) adds rare, résumé-defining experience.

Compensation context: While no salary is disclosed, Director-level commercial roles in U.S. biotech typically range from $180,000-250,000 base, with significant bonus and equity upside. At a NASDAQ-listed company with a Phase 3 asset, stock options carry meaningful potential value if the drug achieves commercial success.

Green flags: Established company with a funded pipeline, tuition assistance, and a learning & development program signal investment in talent. Watch for: The 50-75% travel demand is substantial and can accelerate burnout at Director level - clarify expectations around weekend travel compensation and work-life norms during interviews.

Who We Are:

Xenon Pharmaceuticals ( NASDAQ: XENE ) is a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development, and commercialization of life-changing therapeutics for patients in need. We are looking for great people who thrive in a respectful, collaborative, inclusive, and productive culture to join the Xenon team.

What We Do:

We are advancing an exciting product pipeline to address indications with high unmet medical need, including epilepsy, depression, and pain. Our Phase 3 azetukalner program represents the most advanced, clinically validated potassium channel modulator in late-stage clinical development for multiple indications. In March 2026, we announced positive topline data from our Phase 3 X-TOLE2 study of azetukalner in focal onset seizures (FOS), and we submitted a New Drug Application to the FDA in Q3 2026.

Our Phase 3 epilepsy program also includes a second FOS study (X-TOLE3) to support regulatory submissions outside the U.S., and the X-ACKT study in primary generalized tonic-clonic seizures for an additional epilepsy indication. We also have multiple Phase 3 azetukalner clinical trials underway in major depressive disorder (MDD) and bipolar depression (BPD), based on Phase 2 X-NOVA data. We continue to advance an early-stage pipeline including Phase 1 studies for XEN1701 and XEN1720 (targeting Nav1.7) and XEN1120 (targeting Kv7) for pain. Backed by a strong balance sheet, we are building a fully integrated, premier neuroscience company.

About the Role:

We are seeking a Director, Strategic Engagements, Northeast to join our Commercial team. This individual will support commercially focused HCP engagement activities for Azetukalner, with a primary responsibility of supporting key US Commercial Strategic market development strategies for the epilepsy launch.

The ideal candidate is an exceptional business leader with deep epilepsy experience who will work regionally to: (1) drive KOL engagement, (2) uncover key market impact drivers, and (3) support regional business planning across matrix colleagues. This role requires close working relationships with cross-functional partners in a compliant manner, collaborating with Commercial, Medical Affairs, and other key business partners to elevate corporate brand awareness and advocacy.

This role requires the ability to thrive in a dynamic and ambiguous environment. Travel is required at greater than 50% and can be up to 75%, including field-based educational events (many occurring on weekends), internal meetings, advisory boards, medical meetings, and congresses.

This position reports to the Senior Director, Customer Engagement, and is fully remote. The region covered includes: MA, NY, PA, NJ, CT, RI, VT, NH, ME.

RESPONSIBILITIES:

  • Identify, cultivate, and maintain long-term relationships with national and regional epilepsy KOLs, advisors, and other influential stakeholders.
  • Own commercial KOL influence mapping, including stakeholder profiling, engagement strategies, and communication plans that inform customer prioritization and commercial planning.
  • Monitor and synthesize stakeholder insights, treatment trends, unmet needs, and competitive dynamics, translating findings into actionable recommendations that inform commercial strategy, launch readiness, and regional business decisions.
  • Serve as a strategic advisor to Commercial leadership by providing market intelligence, stakeholder perspectives, and recommendations that shape launch planning, customer engagement strategies, and business priorities.
  • Support launch readiness initiatives by identifying and engaging key stakeholders whose influence awareness, perception, advocacy, treatment positioning, and early adoption of Azetukalner within assigned regions.
  • Lead cross-functional coordination across Commercial, Medical Affairs, Market Access, Advocacy, and other matrix partners to ensure aligned customer engagement strategies and execution.
  • Drive coordinated account planning by integrating stakeholder insights and partnering across matrix teams to develop and execute aligned engagement plans for priority customers and accounts.
  • Identify emerging market opportunities, barriers to adoption, and customer needs, and recommend actions that strengthen launch preparedness and commercial execution.
  • Attend and lead strategic engagement activities at national and regional congresses, professional meetings and key industry events.
  • Collaborate with Marketing, Analytics, Medical Affairs, and other cross-functional partners to refine disease-state education, brand strategy, customer engagement approaches, and market development initiatives.
  • Identify and develop strategic partnerships with professional societies, advocacy organizations, and other external stakeholders to advance disease awareness, education, and advocacy efforts.
  • Facilitate and coordinate high-impact engagements between Xenon senior leadership and national and regional KOLs.
  • Formalize meetings (live, virtual, Congress) with senior leadership and National and Regional KOLs.
  • Develop and propose short- and long-term objectives for the function in accordance with overall Company strategies and plans.
  • Plan and manage budget proposals and approved budgets in accordance with the Company's strategic and operating plans and Finance policies.
  • Recruit, lead, direct, develop, coach, and evaluate direct reports (if any) in accordance with the Company's Human Resource policies and practices.
  • Act in accordance with Company policies, including the Code of Business Conduct and Ethics, and ensure policies are understood and followed by direct reports (if any).
  • Travel is 50-75%; international travel may be required.
  • Other duties as assigned.

QUALIFICATIONS:

  • A minimum of a BA/BS degree in a related field is required; MBA, PharmD, PhD, or other related graduate degree preferred.
  • A minimum of 10 years of experience in epilepsy marketing, medical affairs, key account management, sales, or sales leadership, ideally engaging with KOLs/influential HCPs and professional healthcare organizations.
  • Deep understanding and experience working cross-functionally with key internal and external stakeholders, with a strong ability to innovate, collaborate, and deliver results with desired outcomes.
  • Demonstrated understanding of key industry trends and ability to develop strategies to stay ahead of the competition and maximize patient outcomes.
  • Demonstrated ability to build and manage relevant and lasting customer relationships with a strong focus on patient impact and outstanding customer centricity.
  • Excellent interpersonal, verbal, and written communication skills.
  • Able to work independently under tight timelines and willing to contribute significantly to day-to-day operations as needed.

Total Rewards:

Our Total Rewards program includes base salary, target bonus, and stock options, as well as a full range of benefits including medical, dental, vision, short- & long-term disability, accidental death & dismemberment, and life insurance programs, Employee Assistance Program, travel insurance, and retirement savings programs with company matching contributions.

Xenon encourages time to rest and re-charge through vacation, personal days, sick days, and an end-of-year company shutdown. Xenon highly values employee development and has an expanding Training, Learning & Development program, including a Tuition Assistance program for advanced degrees.

Is this role truly remote or does it require being in a specific office? The position is listed as fully remote in terms of home base, but it requires 50-75% travel across the Northeast U.S. (MA, NY, PA, NJ, CT, RI, VT, NH, ME) for congresses, advisory boards, and field events, many of which occur on weekends. What level of experience is required for this Director role? A minimum of 10 years of experience in epilepsy marketing, medical affairs, key account management, sales, or sales leadership is required, with a strong track record of engaging KOLs and influential HCPs. What is the compensation structure for this position? No specific salary figures are disclosed, but Xenon's Total Rewards package includes base salary, target bonus, and stock options, plus medical, dental, vision, disability, life insurance, retirement savings with company matching, and tuition assistance. What product will this role support and what stage is it at? This role supports azetukalner, Xenon's lead asset for epilepsy. A New Drug Application was submitted to the FDA in Q3 2026, making this a pre-launch and launch-phase commercial engagement role. Is international travel required for this position? International travel may be required, in addition to the primary 50-75% domestic travel within the Northeast U.S. territory.

Remote work & career advice that actually works.

Get your free, confidential resume review.

or drag and drop your file here.

Similar jobs

Similar jobs worth comparing

Director, Strategic Engagements (Central)
Director, Strategic Engagements (Central)

Xenon Pharmaceuticals • United States

Remote
USD 180,000 - 260,000
Director, Strategic Engagements (Northeast)
Director, Strategic Engagements (Northeast)

Xenon Pharmaceuticals Inc. • Cambridge (MA)

Remote
USD 180,000 - 240,000
Medical, dental, vision
Stock options
Vacation and paid time off
Director, Strategic Engagements (Northeast)
Director, Strategic Engagements (Northeast)

Xenon Pharmaceuticals • United States

Remote
USD 180,000 - 240,000
Stock options
Tuition Assistance
Vacation days
Director, Strategic Engagements (Northeast)
Director, Strategic Engagements (Northeast)

Bazeta • United States

Remote
USD 180,000 - 240,000
Director, Strategic Engagements (Northeast)
Director, Strategic Engagements (Northeast)

pofft Technology Inc. • United States

Remote
USD 190,000 - 260,000
Executive Business Director, East
Executive Business Director, East

Xenon Pharmaceuticals • United States

Remote
USD 180,000 - 240,000
Stock options
Medical, dental, vision benefits
401(k) with company match
Director, National Accounts
Director, National Accounts

Xenon Pharmaceuticals • United States

Remote
USD 180,000 - 270,000
Executive Business Director, West
Executive Business Director, West

Xenon Pharmaceuticals • United States

Remote
USD 180,000 - 240,000
Stock options
Full benefits package
Tuition Assistance program
Executive Business Director, East
Executive Business Director, East

Xenon Pharmaceuticals Inc. • United States

Remote
USD 200,000 - 300,000
Medical benefits
Dental benefits
Vision benefits
+4
Senior Director, Field Access
Senior Director, Field Access

Xenon Pharmaceuticals • United States

Remote
USD 180,000 - 260,000
Stock options
Benefits package (medical, dental, etc
Tuition Assistance program
+1